PT Medikaloka Hermina Tbk (IDX:HEAL)

Market Cap	7.85T -65.7%
Revenue (ttm)	7.37T +5.6%
Net Income	376.85B -11.1%
EPS	24.62 -12.8%
Shares Out	15.25B
PE Ratio	20.92
Forward PE	15.82
Dividend	13.50 (2.62%)
Ex-Dividend Date	May 5, 2026

Volume	13,540,000
Open	515.00
Previous Close	515.00
Day's Range	510.00 - 535.00
52-Week Range	470.00 - 1,530.00
Beta	-0.16
Analysts	Buy
Price Target	1,139.64 (+121.29%)
Est. Earnings	Mar 29, 2027

About PT Medikaloka Hermina Tbk

PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, plastic and reconstructive surgery, neurosurgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, primary care family medicine, nuclear medicine and molecular theranostics, psychiatry, andrology, dietetics, lactation counseling, and dermatology and venereology. It also...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1985
• Employees: 19,235
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: HEAL

Financial Performance

In 2025, PT Medikaloka Hermina Tbk's revenue was 7.13 trillion, an increase of 6.20% compared to the previous year's 6.72 trillion. Earnings were 429.55 billion, a decrease of -19.85%.

Analyst Summary

According to 14 analysts, the average rating for HEAL stock is "Buy." The 12-month stock price target is Rp 1,140, which is an increase of 121.29% from the latest price.

Price Target

Rp 1,140

(121.29% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 30, 2026

Data Sources Report a data error